-
-
-
-
-
-
-
Sensorion Announces Preliminary Positive Data from the First Cohort of the Audiogene Phase 1/2 Gene Therapy Clinical Trial
-
-
-
-
-
-
-
Sensorion Reports Full-Year 2023 Financial Results and Business Update
-
-
-
-
-
-
-
Sensorion Amends Existing Convertible Notes Program Under More Favorable Terms with €10 Million in Financing
-
-
1,173,838 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

